Study of Acamprosate in Driving Under the Influence (DUI) Court Participants
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Acamprosate will be given to approximately 30 DUI Court participants for 3 months and
outcomes will be monitored. The hypothesis is that acamprosate will be safe and
well-tolerated and that subjects' craving and other symptoms related to addiction will
improve over time.